CC BY-NC-ND 4.0 · AJP Rep 2018; 08(02): e51-e56
DOI: 10.1055/s-0038-1639615
Case Report
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Neurocysticercosis in Pregnancy

Camille Webb
1   Division of Infectious Disease, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas
,
Mauricio La Rosa
2   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas
,
Gayle Olson
2   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas
,
Miguel Cabada
1   Division of Infectious Disease, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas
› Author Affiliations
Further Information

Publication History

14 June 2017

13 February 2018

Publication Date:
09 April 2018 (online)

Abstract

The normal physiologic changes during pregnancy contribute to nutritional, metabolic, and immunologic adjustments, which can have an impact on the presentation of several diseases. New onset seizures during pregnancy and the postpartum can be attributed to several etiologies. Patient demographic data as well as personal and social histories are key in determining the etiology of new onset seizures. Neurocysticercosis (NCC), a commonly overlooked etiology, must be included in the differential diagnosis of patients with new onset seizures coming from NCC endemic areas. The diagnosis is based on a combination of clinical findings, exposure history, imaging, and serology. We present two cases of patients with NCC that became symptomatic during pregnancy or postpartum period. We will review the epidemiology, clinical manifestations, and management of NCC in pregnancy.

 
  • References

  • 1 Coyle CM, Mahanty S, Zunt JR. , et al. Neurocysticercosis: neglected but not forgotten. PLoS Negl Trop Dis 2012; 6 (05) e1500
  • 2 Garcia H, Coyle C, White Jr A. Cysticercosis. In: Guerrant R, Walker D, Weller P. , eds. Tropical Infectious Diseases, Principles, Pathogens and Practice. Philadelphia: Elsevier-Saunders; 2011: 815-823
  • 3 Webb CM, White Jr AC. Update on the diagnosis and management of neurocysticercosis. Curr Infect Dis Rep 2016; 18 (12) 44
  • 4 Budke CM, White Jr AC, Garcia HH. Zoonotic larval cestode infections: neglected, neglected tropical diseases?. PLoS Negl Trop Dis 2009; 3 (02) e319
  • 5 Ong S, Talan DA, Moran GJ. , et al; EMERGEncy ID NET Study Group. Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis 2002; 8 (06) 608-613
  • 6 O'Keefe KA, Eberhard ML, Shafir SC, Wilkins P, Ash LR, Sorvillo FJ. Cysticercosis-related hospitalizations in the United States, 1998-2011. Am J Trop Med Hyg 2015; 92 (02) 354-359
  • 7 O'Neal SE, Flecker RH. Hospitalization frequency and charges for neurocysticercosis, United States, 2003-2012. Emerg Infect Dis 2015; 21 (06) 969-976
  • 8 Centers for Disease Control (CDC). Locally acquired neurocysticercosis--North Carolina, Massachusetts, and South Carolina, 1989-1991. MMWR Morb Mortal Wkly Rep 1992; 41 (01) 1-4
  • 9 Moore AC, Lutwick LI, Schantz PM. , et al. Seroprevalence of cysticercosis in an Orthodox Jewish community. Am J Trop Med Hyg 1995; 53 (05) 439-442
  • 10 Kurl R, Montella KR. Cysticercosis as a cause of seizure disorder in pregnancy: case report and review of literature. Am J Perinatol 1994; 11 (06) 409-411
  • 11 Singhal SR, Nanda S, Singhal SK. Neurocysticercosis as an important differential of seizures in pregnancy: two case reports. J Med Case Reports 2011; 5: 206
  • 12 Dick GWA, Kitchen SF, Haddow AJ. Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg 1952; 46 (05) 509-520
  • 13 Gardner E, Chang M, Mancuso P, Chaney SE. Neurocysticercosis in pregnancy: not just another headache. Nurs Womens Health 2012; 16 (02) 118-124
  • 14 Grondin L, D'Angelo R, Thomas J, Pan PH. Neurocysticercosis masquerading as eclampsia. Anesthesiology 2006; 105 (05) 1056-1058
  • 15 Sahai S, Sahai A. Pica causing neurocysticercosis in pregnancy presenting as eclampsia: a report of two cases. J Obstet Gynaecol India 2013; 63 (01) 68-69
  • 16 Suarez VR, Iannucci TA. Neurocysticercosis in pregnancy: a case initially diagnosed as eclampsia. Obstet Gynecol 1999; 93 (5 Pt 2): 816-818
  • 17 Eke AC, Ezebialu IU, Okafor C. Presentation and outcome of eclampsia at a tertiary center in South East Nigeria--a 6-year review. Hypertens Pregnancy 2011; 30 (02) 125-132
  • 18 World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. Geographic variation in the incidence of hypertension in pregnancy. Am J Obstet Gynecol 1988; 158 (01) 80-83
  • 19 Liu S, Joseph KS, Liston RM. , et al; Maternal Health Study Group of Canadian Perinatal Surveillance System (Public Health Agency of Canada). Incidence, risk factors, and associated complications of eclampsia. Obstet Gynecol 2011; 118 (05) 987-994
  • 20 Douglas KA, Redman CW. Eclampsia in the United Kingdom. BMJ 1994; 309 (6966): 1395-1400
  • 21 Aegidius K, Zwart JA, Hagen K, Stovner L. The effect of pregnancy and parity on headache prevalence: the Head-HUNT study. Headache 2009; 49 (06) 851-859
  • 22 Pandian JD, Venkateswaralu K, Thomas SV, Sarma PS. Maternal and fetal outcome in women with epilepsy associated with neurocysticercosis. Epileptic Disord 2007; 9 (03) 285-291
  • 23 Bonney EA. Immune regulation in pregnancy: a matter of perspective?. Obstet Gynecol Clin North Am 2016; 43 (04) 679-698
  • 24 Arce-Sillas A, Álvarez-Luquín DD, Cárdenas G. , et al. Interleukin 10 and dendritic cells are the main suppression mediators of regulatory T cells in human neurocysticercosis. Clin Exp Immunol 2016; 183 (02) 271-279
  • 25 Omer SB. Maternal immunization. N Engl J Med 2017; 376 (13) 1256-1267
  • 26 Conti E, Zezza L, Ralli E. , et al. Growth factors in preeclampsia: a vascular disease model. A failed vasodilation and angiogenic challenge from pregnancy onwards?. Cytokine Growth Factor Rev 2013; 24 (05) 411-425
  • 27 Asnis D, Kazakov J, Toronjadze T. , et al. Neurocysticercosis in the infant of a pregnant mother with a tapeworm. Am J Trop Med Hyg 2009; 81 (03) 449-451
  • 28 Del Brutto OH, Nash TE, White Jr AC. , et al. Revised diagnostic criteria for neurocysticercosis. J Neurol Sci 2017; 372: 202-210
  • 29 Carod JF, Randrianarison M, Razafimahefa J. , et al. Evaluation of the performance of 5 commercialized enzyme immunoassays for the detection of Taenia solium antibodies and for the diagnosis of neurocysticercosis. Diagn Microbiol Infect Dis 2012; 72 (01) 85-89
  • 30 Gabriël S, Blocher J, Dorny P. , et al. Added value of antigen ELISA in the diagnosis of neurocysticercosis in resource poor settings. PLoS Negl Trop Dis 2012; 6 (10) e1851
  • 31 Deckers N, Dorny P. Immunodiagnosis of Taenia solium taeniosis/cysticercosis. Trends Parasitol 2010; 26 (03) 137-144
  • 32 Gonzalez AE, Bustos JA, Garcia HH. , et al; Cysticercosis Working Group in Peru. Successful antiparasitic treatment for cysticercosis is associated with a fast and marked reduction of circulating antigen levels in a naturally infected pig model. Am J Trop Med Hyg 2015; 93 (06) 1305-1310
  • 33 Fleury A, Garcia E, Hernández M. , et al. Neurocysticercosis: HP10 antigen detection is useful for the follow-up of the severe patients. PLoS Negl Trop Dis 2013; 7 (03) e2096
  • 34 Gonzales I, Rivera JT, Garcia HH. ; Cysticercosis Working Group in Peru. Pathogenesis of Taenia solium taeniasis and cysticercosis. Parasite Immunol 2016; 38 (03) 136-146
  • 35 Nash TE, Mahanty S, Loeb JA. , et al. Neurocysticercosis: a natural human model of epileptogenesis. Epilepsia 2015; 56 (02) 177-183
  • 36 Crawford P. Epilepsy and pregnancy. Seizure 2002; 11 (Suppl A): 212-219
  • 37 Rajshekhar V, Jeyaseelan L. Seizure outcome in patients with a solitary cerebral cysticercus granuloma. Neurology 2004; 62 (12) 2236-2240
  • 38 Mejia R, Nash TE. Corticosteroid withdrawal precipitates perilesional edema around calcified Taenia solium cysts. Am J Trop Med Hyg 2013; 89 (05) 919-923
  • 39 Browne IM, Birnbach DJ. Neurocysticercosis: a new differential in the diagnosis of postdural puncture headache. Anesth Analg 2003; 97 (02) 580-582 table of contents
  • 40 D'Cruz RF, Ng SM, Dassan P. Neurocysticercosis in pregnancy: maternal and fetal outcomes. Oxf Med Case Rep 2016; 2016 (07) 138-140
  • 41 Fica C A, Castro S M, Soto S A, Flores M C, Oelker B C, Weitzel T. [Neurocysticercosis: an neglected disease in Chile]. Rev Chilena Infectol 2012; 29 (01) 72-81
  • 42 Ramus RM, Girson M, Twickler DM, Wendel GD. Acute obstructive hydrocephalus due to cysticercosis during pregnancy. Infect Dis Obstet Gynecol 1994; 1 (04) 198-201
  • 43 Bazley WS. Maternal mortality due to cysticercus cerebri. A case report. Obstet Gynecol 1972; 39 (03) 362-367
  • 44 Thaker HK, Tacconi L, Snow MH. Neurocysticercosis in pregnancy. Br J Neurosurg 2001; 15 (03) 284
  • 45 Forsbach G, Iris S, Zárate A, Azuela JC, Canales ES. Empty sella syndrome due to cysticercosis cerebri in a pregnant woman. Rev Invest Clin 1976; 28 (01) 33-35
  • 46 Torsone A, McMahon MJ. A guest editorial: neurocysticercosis. Obstet Gynecol Surv 2000; 55 (08) 465-467
  • 47 Gowri V, Jacob PC, Jain R, Sawhney S. Neurocysticercosis in pregnancy. Neurosciences (Riyadh) 2005; 10 (02) 183-185
  • 48 Paparone PW, Menghetti RA. Case report: neurocysticercosis in pregnancy. N J Med 1996; 93 (02) 91-94